The headline reads as positive (90% confidence from the FinBERT financial-language model), so the stock went through the full analysis. The rest of the picture is mixed, so the headline alone is not enough for a clear call.
Stocks › AM
Antero Midstream Corp (AM) stock analysis
SKIP 1% confidence · analysed Oct 29, 2026
On Oct 29, 2026, our model rated Antero Midstream Corp (AM) SKIP with 1% confidence at a price of $21.52. That means the signals cancel out; the model sees no clear edge either way.
Analysed price$21.52
Technical picture
The 14-day RSI is 58, showing healthy upward momentum without being stretched.
MACD is above its signal line, a sign that short-term momentum is turning up.
The price is above both its 50-day and 200-day moving averages, the classic picture of an uptrend.
Volume is 2.2x its 20-day average, so the latest move has real participation behind it.
Trend structure and money flow
Market structure: ranging / no clear structure.
The most recent swing high is $23.10 and the swing low is $19.76; traders often treat these as resistance and support.
Fundamentals
The company reports a profit margin of 30.4% and revenue growth of +8.3%.
In its latest quarter it earned $0.28 per share, which missed the $0.36 analysts expected, with revenue +12.0% year over year.
Wall Street's average rating is 2.9 on a 1 (strong buy) to 5 (sell) scale, roughly a "hold", with an average price target of $24.00.
The next earnings report is expected around Feb 10, 2027; prices often move sharply around earnings.
Research notes
AM (Amwell) bull case: subscription revenue is stabilizing, now exceeding half of sales, while management has raised 2026 revenue and adjusted-EBITDA guidance; a potential direct, multi-year Defense Health Agency contract could materially expand the business. Bear case: near-term revenue and EBITDA are expected to decline, the company still forecasts a 2026 EBITDA loss of $7–$9 million, and the DHA award remains unsigned with uncertain timing and economics. The major recent catalyst is the DHA’s stated intent to award Amwell a sole-source contract, replacing its pass-through arrangement through Leidos, while the stock’s roughly 21% post-report gain has increased expectations for execution.
The model's one-paragraph read
No clear edge (SKIP) — composite score +0.01 (SKIP). Technicals: RSI 58.29, MACD bullish, price above SMA50. Fundamentals: margin 30.4%, revenue growth 8.3%. Financial results: YoY revenue +12.0%, last EPS surprise -22.2%, next earnings 2027-02-10. Smart Money Concepts: ranging / no clear structure. FinGPT news read: positive. Internet research: AM (Amwell) bull case: subscription revenue is stabilizing, now exceeding half of sales, while management has raised 2026 revenue and adjusted-EBITDA guidance; a potential direct, multi-year Defense Health Agency contract could materially expand the business. Bear case: near-term revenue and EBITDA are expected to decline, the company still forecasts a 2026 EBITDA loss of $7–$9 million, and the DHA award remains unsigned with uncertain timing and economics. The major recent catalyst is the DHA’s stated intent to award Amwell a sole-source contract, replacing its pass-through arrangement through Leidos, while the stock’s roughly 21% post-report gain has increased expectations for execution. Reference price $21.52; no trade levels (SKIP).
Past ratings for AM
| Date | Verdict | Confidence | Price | Move since | |
|---|---|---|---|---|---|
| Oct 29, 2026 | SKIP | 1% | $21.52 | — |
"Move since" compares each call's price with the latest analysed price.
Recent news on AM
Oct 29, 2026 · Antero Midstream's Litigation-Fueled Beat Masks A Flat Quarter, But A Stronger 2027 Outlook Raises The Stakes
- Oct 29, 2026: Antero Midstream's Litigation-Fueled Beat Masks A Flat Quarter, But A Stronger 2027 Outlook Raises The Stakes (Earnings Whispers)
- Oct 29, 2026: Antero Midstream Corporation Reports Third Quarter 2026 Results and Updates Full Year Guidance (Nasdaq)
Frequently asked questions
Is AM a buy right now?
As of Oct 29, 2026, our automated model rates Antero Midstream Corp (AM) SKIP with 1% confidence: the signals cancel out; the model sees no clear edge either way. This is a model output for education, not personal investment advice.
When does Antero Midstream Corp report earnings next?
The next earnings report is expected around Feb 10, 2027.
What does a SKIP rating mean?
A SKIP rating means the signals cancel out; the model sees no clear edge either way.
For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.